Treatment access is only the first step to hepatitis C elimination: experience of universal anti‐viral treatment access in Australia

• Published in: Alimentary pharmacology & therapeutics Vol. 49; no. 9; pp. 1223 - 1229
• Main Authors: Doyle, Joseph S., Scott, Nick, Sacks‐Davis, Rachel, Pedrana, Alisa E., Thompson, Alexander J., Hellard, Margaret E., Hellard, Margaret, Thompson, Alex, Doyle, Joseph, Dietze, Paul, McBryde, Emma, Sievert, William, Stoove, Mark, Higgs, Peter, Petrie, Denis, Vickerman, Peter
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01.05.2019
• Subjects: Antiviral Agents - classification; Antiviral Agents - therapeutic use; Australia - epidemiology; Disease Eradication - methods; Disease Eradication - standards; Disease Eradication - statistics & numerical data; Early Medical Intervention - standards; Early Medical Intervention - statistics & numerical data; General Practitioners - statistics & numerical data; Health Services Accessibility - standards; Health Services Accessibility - statistics & numerical data; Hepacivirus - immunology; Hepatitis; Hepatitis C; Hepatitis C - diagnosis; Hepatitis C - drug therapy; Hepatitis C - epidemiology; Hepatitis C Antibodies - analysis; Hepatitis C Antibodies - blood; Hepatitis C, Chronic - diagnosis; Hepatitis C, Chronic - drug therapy; Hepatitis C, Chronic - epidemiology; Humans; Infectious diseases; Mass Screening - methods; Mass Screening - standards; Mass Screening - statistics & numerical data; Practice Patterns, Physicians' - statistics & numerical data; Rural Population - statistics & numerical data; Specialization - statistics & numerical data; Australia

Summary Background Global targets to eliminate hepatitis C (HCV) might be met by sustained treatment uptake. Aim To describe factors facilitating HCV treatment uptake and potential challenges to sustaining treatment levels after universal access to direct‐acting anti‐virals (DAA) across Australia. M...